Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Player

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 25, 2007
2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitorsLily Lee, Kevin D Kreutter, Wenxi Pan, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2006
Identification of 2-acylaminothiophene-3-carboxamides as potent inhibitors of FLT3Raymond J Patch, Christian A Baumann, Jian Liu, et al.
Critical Care Medicine|March 6, 2014
Transient receptor potential melastatin 8 channel inhibition potentiates the hypothermic response to transient receptor potential vanilloid 1 activation in the conscious mouseViktor V Feketa, Yi Zhang, Zhijuan Cao, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 1, 1994
Scale for assessing functional impairment in adults with asthmaR Player, J M Richards, C L Kohler, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumoniaT M File, J Segreti, L Dunbar, et al.
Journal of Medicinal Chemistry|May 23, 1998
Nuclease-resistant composite 2',5'-oligoadenylate-3', 5'-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisenseW Xiao, G Li, M R Player, et al.
Nucleosides & Nucleotides|September 4, 1999
2-5A-PNA complexes: a novel class of antisense compoundsJ C Verheijen, S F Bayly, M R Player, et al.
Bioorganic & Medicinal Chemistry|April 29, 1999
2,5-oligoadenylate-peptide nucleic acids (2-5A-PNAs) activate RNase LJ C Verheijen, G A van der Marel, J H van Boom, et al.
Clinical Therapeutics|April 25, 2001
Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trialsC M Fogarty, R N Greenberg, L Dunbar, et al.
Chemical Biology & Drug Design|August 23, 2006
Exploration of potential prodrugs of RWJ-445167, an oxyguanidine-based dual inhibitor of thrombin and factor XaBruce E Maryanoff, David F McComsey, Michael J Costanzo, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|September 25, 2007
2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitorsLily Lee, Kevin D Kreutter, Wenxi Pan, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2006
Identification of 2-acylaminothiophene-3-carboxamides as potent inhibitors of FLT3Raymond J Patch, Christian A Baumann, Jian Liu, et al.
Critical Care Medicine|March 6, 2014
Transient receptor potential melastatin 8 channel inhibition potentiates the hypothermic response to transient receptor potential vanilloid 1 activation in the conscious mouseViktor V Feketa, Yi Zhang, Zhijuan Cao, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 1, 1994
Scale for assessing functional impairment in adults with asthmaR Player, J M Richards, C L Kohler, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumoniaT M File, J Segreti, L Dunbar, et al.
Journal of Medicinal Chemistry|May 23, 1998
Nuclease-resistant composite 2',5'-oligoadenylate-3', 5'-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisenseW Xiao, G Li, M R Player, et al.
Nucleosides & Nucleotides|September 4, 1999
2-5A-PNA complexes: a novel class of antisense compoundsJ C Verheijen, S F Bayly, M R Player, et al.
Bioorganic & Medicinal Chemistry|April 29, 1999
2,5-oligoadenylate-peptide nucleic acids (2-5A-PNAs) activate RNase LJ C Verheijen, G A van der Marel, J H van Boom, et al.
Clinical Therapeutics|April 25, 2001
Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trialsC M Fogarty, R N Greenberg, L Dunbar, et al.
Chemical Biology & Drug Design|August 23, 2006
Exploration of potential prodrugs of RWJ-445167, an oxyguanidine-based dual inhibitor of thrombin and factor XaBruce E Maryanoff, David F McComsey, Michael J Costanzo, et al.
Pageof 8